Emma Danks

Emma Danks is head of our private equity team and co-head of our global corporate/M&A group. She is recognised as one of the UK’s leading private equity lawyers and is described by clients as bright, commercial, and solutions focused. Emma is well known for her work with private equity sponsors and their portfolio companies, having acted on a wide range of leveraged buyouts and related transactions. She also frequently advises private equity backed management teams on buyout transactions and equity plans.

Emma also has specific life sciences and healthcare experience, having acted for several generic pharmaceutical companies on both buy-side and sell-side M&A transactions.

Emma was listed in The Lawyer's Hot 100 for 2018, and in the Legal Business feature on the City's female deal stars. Her team’s buyout expertise was recently recognised when they were named Private Equity Team of the Year at the British Legal Awards.

Show full CV Hide full CV

Career

Since 2017	Head of the Private Equity group, co-head of the International Corporate group, Taylor Wessing
2010	Partner, Taylor Wessing
2006 - 2010	Senior Associate, Clifford Chance

2001 - 2006	Associate, Clifford Chance
1999 - 2001	Trainee, Clifford Chance

More Less

Education

2001	Admitted as a lawyer, England & Wales
1998	CPE and LPC, College of Law, Guildford
1996	MA Hons Newnham College, University of Cambridge

Publications

Private Equity Exits “A Practical Analysis", October 2011
PLC Cross Border Private Equity Handbook, 2010

Expertise

Sectors Technology, media & communications Consumer & retail Real estate Life sciences & healthcare

Experience

BentallGreenOak on the acquisition of prime logistics portfolio	We have advised BentallGreenOak on the acquisition of a seven-asset strong logistics portfolio from Morgan Stanley Real Estate Investing. The platform includes seven logistics assets, totalling 2.18m sq ft. Over 80% of the portfolio is let to tenants such as Sainsburys, British Gas, DSV and Clipper on core logistics parks including Magna Park, Lutterworth, D.I.R.F.T, Hams Hall and Warth Park.
Glenmark Pharma on the sale of its portfolio of CNS products in Poland to Neuraxpharm	Glenmark Pharma on its divestment of its CNS business in Poland including its portfolio of generics and branded generics products and the transfer of its commercial team in Poland to private equity backed Neuraxpharm, a specialty pharmaceutical company focused on the treatment of CNS disorders.
Affirma Capital on its MBO of Standard Chartered Bank's private equity investment business	Affirma Capital, a newly formed, independent private equity firm owned and managed by the former senior leadership of Standard Chartered Private Equity (SCPE), on its MBO of Standard Chartered Bank's (SCB) private equity investment business. The deal was complex, involving the acquisition by Affirma Capital of the general partners and investment managers of various third party funds being spun out from within SCB, as well as the establishment of a new fund backed by ICG and incorporation of investment adviser entities in Affirma Capital's key jurisdictions.

Apotex's EUR74m sale of subsidiaries to Aurobindo	Apotex on the sale of six European subsidiaries in Belgium, Poland, the Netherlands, Czech Republic and Spain, to Aurobindo for EUR74 million. This highly complex transaction involved the share transfer of subsidiaries in multiple jurisdictions being co-ordinated and managed by our UK team. We simultaneously advised on a multitude of business separation, ongoing product supply agreements and IP licences for the European business to continue operating after being removed from the Apotex group.
Longstanding client Rutland Partners on the sale of Pizza Hut Restaurants	Rutland Partners on the sale of Pizza Hut Restaurants UK to its existing management team led by Jens Hofma (CEO). The disposal concludes an extremely successful investment for Rutland Fund II. Rutland first acquired Pizza Hut Restaurants UK (excluding the Delivery Business) in November 2012 from the global franchisor, Yum! Brands.
Riverstone Living on key joint venture in the senior living sector	Advised on a joint venture between with Goldman Sachs to develop and manage assisted living facilities in Greater London.

More Less

Awards

Chambers UK 2022	Private Equity: Buyouts - Mid Market: "Emma Danks exhibits a strong command of private equity buyouts and ancillary transactions on behalf of sponsors and their portfolio companies. She heads the firm's private equity practice and is co-head of its global corporate group."
Legal 500 UK 2022	M&A - lower mid-market deals, £50m-£500m (Leading individual)
Legal 500 UK 2022	Private equity transactions – mid-tier – up to £250m (Leading individual)
The Lawyer Awards 2020	Corporate team of the year - work with Affirma Capital, coordinating a multi-faceted cross-border private equity transaction
IFLR 1000 2020	Notable practitioner: Private equity, M&A (UK)
Legal Week British Legal Awards 2019	Private Equity Team of the Year (Transactional) - Affirma Capital on the acquisition of Standard Chartered's private equity business for GPB790m
Chambers UK 2020	Leading individual - Private Equity: Venture Capital Investment (Band 3)
Chambers UK 2020	Leading individual - Private Equity: Buyouts: Mid-Market (Band 3): Emma Danks heads the firm's private equity team and is sought after by domestic and international houses, and their portfolio companies, to assist in a range of transactions. A client says: "Emma is good at thinking through what protections you need, how to approach things and thinking through to solutions."
Legal 500 UK 2020	Leading individual - Corporate and commercial: Private equity: transactions
Legal 500 UK 2020	Leading individual - Corporate and commercial: M&A: mid-market deals, £50m-£500m
The Lawyer’s ‘Hot 100 Listing’ UK 2018	Named as one of the top 100 lawyers in the UK
Chambers UK 2018	Leading individual - Private Equity (Buyouts) (Band 4): Emma Danks "goes the extra mile" for her clients, which include both corporates and leading private equity houses. Her practice encompasses M&A work, LBOs, MBOs and work for investee companies.

Meet me at

There are no upcoming events

See all events